Perceptive Advisors LLC Mirati Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $30.9 Million - $42.3 Million	-855,031 Reduced 54.32%	719,103 $26 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $22.6 Million - $33.5 Million	-617,291 Reduced 28.17%	1,574,134 $58.5 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $24.5 Million - $58.5 Million	-593,371 Reduced 21.31%	2,191,425 $99.3 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $4.88 Million - $7.12 Million	-82,067 Reduced 2.86%	2,784,796 $194 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $19 Million - $43.1 Million	486,153 Added 20.42%	2,866,863 $192 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $68.5 Million - $136 Million	-903,073 Reduced 27.5%	2,380,710 $196 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $13.7 Million - $19.8 Million	-103,962 Reduced 3.07%	3,283,783 $482 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $26.7 Million - $35.8 Million	201,847 Added 6.34%	3,387,745 $599 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $41.6 Million - $51.9 Million	-288,607 Reduced 8.31%	3,185,898 $515 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $34.8 Million - $48.5 Million	-219,011 Reduced 5.93%	3,474,505 $595 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $41.8 Million - $62 Million	257,941 Added 7.51%	3,693,516 $811 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $75.3 Million - $111 Million	664,525 Added 23.98%	3,435,575 $570 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $39.5 Million - $66 Million	-548,400 Reduced 16.52%	2,771,050 $316 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $8.1 Million - $13.5 Million	116,044 Added 3.62%	3,319,450 $255 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $7.87 Million - $14.3 Million	-111,200 Reduced 3.35%	3,203,406 $413 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $32.3 Million - $45.5 Million	415,000 Added 14.31%	3,314,606 $258 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $103 Million - $182 Million	1,735,224 Added 149.03%	2,899,606 $299 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $45.3 Million - $82 Million	1,038,507 Added 825.03%	1,164,382 $85.3 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $4.03 Million - $5.97 Million	125,875 New	125,875 $5.25 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $33.6 Million - $44.7 Million	-713,191 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $17.8 Million - $35.8 Million	684,100 Added 2351.59%	713,191 $35.2 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $368,001 - $552,729	29,091	29,091 $531,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account